Uncategorized

EMPOWER CLINICS INC announces that the company is officially launching the PulseIR technology platform, a personalized, automated, and data-driven mobile IR solution from the PulseIR subsidiary of Fobi AI.

This agreement is a significant step for Aditxt as it expands its portfolio to include innovative therapies for infectious diseases.

Ondine Biomedical (OBI:LON), a Canadian life sciences company, reported that photodisinfection being developed for food processing demonstrated high efficacy against key food-borne pathogens.

Han creado un singular robot con forma de semilla y con capacidad para moverse por la tierra en función de los cambios de humedad. Es de pequeño tamaño, está hecho de materiales biodegradables y es capaz de desplazarse sin necesidad de baterías u otras fuentes exte …

En este Short nos preguntamos por qué razón biológica tenemos cosquillas los humanos.     …

Lannett Company, Inc. (LCI) (“Lannett” or “the Company”) today announced that it received a written notice from the New York Stock Exchange (“NYSE”) dated April 19, 2023, notifying the Company that the NYSE will commence proceedings to delist the Company’s common stock from the NYSE.

Haemonetics Corporation today announced the release of its 2022 Corporate Responsibility Report.

Promore Pharma In the light of the publication of the results from the clinical trial PHSU05, Promore Pharma AB invites to a webcast on Friday 21 April kl 10.00

Immunovia announced it will participate in a webinar titled “Biomarkers and Liquid Biopsy for Early Detection of Pancreatic Cancer” hosted by the National Pancreas Foundation on April 26, 2023, at 7:00 pm ET.

Promore Pharma AB announces that the results from the company’s Phase II study PHSU05 with ensereptide in prevention of skin scarring have been concluded.